Meningococcal Group B Vaccine
Showing 26 - 50 of >10,000
Meningococcal Infection (Healthy Volunteers) Trial in Worldwide (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)
Completed
- Meningococcal Infection (Healthy Volunteers)
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
- +3 more
-
Budapest, Hungary
- +22 more
May 18, 2022
Meningococcal Disease, Pneumococcal Disease, Haemophilus Influenzae Serotype b Disease Trial in London (Menjugate, Menitorix,
Completed
- Meningococcal Disease
- +4 more
- Menjugate
- +2 more
-
London, United KingdomSt George's Vaccien Institute
Sep 29, 2020
Infections, Meningococcal Trial in Worldwide (Meningococcal vaccine GSK134612, Prevenar 13™)
Completed
- Infections, Meningococcal
- Meningococcal vaccine GSK134612
- Prevenar 13™
-
Garran, Australian Capital Territory, Australia
- +50 more
Sep 7, 2021
Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)
Not yet recruiting
- Rabies
- 5-dose group of test vaccine
- +3 more
-
Chengdu, Sichuan, China
- +3 more
Jul 23, 2023
Propositive Follow-up Study
Recruiting
- HIV/AIDS
- Meningococcal Disease
- Serum Bactericidal Assays
-
London, United KingdomSt George's University of London
Jan 27, 2022
Diarrhoea Trial in Gent (drug, biological, combination product)
Recruiting
- Diarrhoea
- altSonflex Placebo
- +8 more
-
Gent, BelgiumGSK Investigational Site
Apr 18, 2022
Meningococcal Vaccine Trial in Worldwide (MenABCWY, Saline, rLP2086)
Completed
- Meningococcal Vaccine
- MenABCWY
- +3 more
-
Birmingham, Alabama
- +68 more
Jan 23, 2023
Meningoccocal Disease, Meningococcal Meningitis Trial in Hungary, Spain (Bexsero® vaccine (1 dose at study month zero), Bexsero®
Completed
- Meningoccocal Disease
- Meningococcal Meningitis
- Bexsero® vaccine (1 dose at study month zero)
- Bexsero® vaccine (2 doses 1 month apart)
-
Debrecen, Bajcsi Ut 32, Hungary
- +16 more
Nov 24, 2021
Group B Streptococcal Infections Trial in Ghent (GBS-NN/NN2, Placebo)
Recruiting
- Group B Streptococcal Infections
- GBS-NN/NN2
- Placebo
-
Ghent, BelgiumUniversity Hospital Ghent - Centrum voor Vaccinologie (CEVAC) de
Mar 21, 2023
Meningococcal Infections Trial in Oakland, Worcester (Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals))
Completed
- Meningococcal Infections
- Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals)
-
Oakland, California
- +1 more
Feb 1, 2021
Vaccine for Meningococcal Disease Trial in India (NmCV-5, Menactra)
Completed
- Vaccine for Meningococcal Disease
- NmCV-5
- Menactra
-
New Delhi, Delhi, India
- +10 more
Sep 4, 2021
Healthy Volunteers (Meningococcal Infection) Trial in Puerto Rico, United States (Meningococcal polysaccharide (serogroups A,C,Y
Active, not recruiting
- Healthy Volunteers (Meningococcal Infection)
- Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine)
- +7 more
-
Birmingham, Alabama
- +68 more
Jan 3, 2023
Covid19 Trial in Australia (SII B.1.351, SII Bivalent, SII B.1.617.2)
Withdrawn
- Covid19
- SII B.1.351
- +2 more
-
Maroubra, New South Wales, Australia
- +3 more
May 25, 2022
Invasive Meningococcal Disease Trial in Poland, United States (Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria
Completed
- Invasive Meningococcal Disease
- Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.
- +3 more
-
Birmingham, Alabama
- +12 more
Jun 11, 2020
Influenza, Human Trial in Birmingham (Treatment Group Live Attenuated Flu Vaccine (LAIV))
Completed
- Influenza, Human
- Treatment Group Live Attenuated Flu Vaccine (LAIV)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 16, 2022
Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Neoantigen Dendritic Cell Vaccine
- Nivolumab
-
Singapore, SingaporeNational Cancer Center Singapore
Aug 17, 2022
Group B Streptococcal Infection Trial in Johannesburg, Kawempe (GBS-NN/NN2, Placebo)
Active, not recruiting
- Group B Streptococcal Infection
- GBS-NN/NN2
- Placebo
-
Johannesburg, South Africa
- +2 more
Aug 29, 2022
Group B Streptococcus Infections Trial in United States (Multivalent Group B streptococcus vaccine, Tetanus, diphtheria, and
Not yet recruiting
- Group B Streptococcus Infections
- Hexavalent Group B streptococcus vaccine
- +2 more
- (no location specified)
Jan 6, 2022
Infections, Meningococcal Trial in Worldwide (MenABCWY-2Gen low dose vaccine, MenABCWY-2Gen high dose vaccine, MenABCWY-1Gen
Recruiting
- Infections, Meningococcal
- MenABCWY-2Gen low dose vaccine
- +4 more
-
Espoo, Finland
- +36 more
Dec 22, 2022
Hematopoietic Stem Cell Transplant, Meningococcal Vaccine Trial in Créteil (B vaccination)
Completed
- Hematopoietic Stem Cell Transplant
- Meningococcal Vaccine
- B vaccination
-
Créteil, Val De Marne, FranceHenri-Mondor Hospital
Oct 23, 2020
Meningitis, Meningococcal Trial in Kunming (Experimental Group A meningococcal polysaccharide vaccine, Control Group A
Recruiting
- Meningitis, Meningococcal
- Experimental Group A meningococcal polysaccharide vaccine
- Control Group A meningococcal polysaccharide vaccine
-
Kunming, Yunnan, ChinaYunnan Center for Disease Control and Prevention
Dec 28, 2020
Diphtheria, Tetanus, Pertussis Trial (DTaP-HepB-IPV-Hib vaccine)
Not yet recruiting
- Diphtheria
- +5 more
- DTaP-HepB-IPV-Hib vaccine
- (no location specified)
Jul 11, 2023
Meningococcal Vaccine Trial in Finland, Poland, Spain (Nimenrix)
Completed
- Meningococcal Vaccine
- Nimenrix
-
Tampere, Pirkanmaa, Finland
- +13 more
Oct 10, 2022
Meningitis, Meningococcal Trial in Kunming (Experimental Group A and C meningococcal polysaccharide vaccine, Control Group A and
Recruiting
- Meningitis, Meningococcal
- Experimental Group A and C meningococcal polysaccharide vaccine
- Control Group A and C meningococcal polysaccharide vaccine
-
Kunming, Yunnan, ChinaYunnan Center for Disease Control and Prevention
Dec 28, 2020
Pneumococcal Disease Trial in Hialeah, Elkridge, San Antonio (Low dose multivalent pneumococcal conjugate vaccine formulation A,
Recruiting
- Pneumococcal Disease
- Low dose multivalent pneumococcal conjugate vaccine formulation A
- +3 more
-
Hialeah, Florida
- +2 more
Apr 27, 2023